Dr. James Gerald Carlisle, MD

Dr. Carlisle practices at Wasatch Vascular Care - Salt Lake City in Salt Lake City, Utah.

Dr. Carlisle's NPI, 1750478707, was assigned on October 9, 2006. Dr. Carlisle graduated from University Of Michigan Medical School in 1991. Dr. Carlisle holds Utah license 5617957-1205.

Dr. Carlisle's primary practice is Wasatch Vascular Care - Salt Lake City, at 3702 S State Street Suite 103, Salt Lake City, UT 84115. The practice phone is (727) 916-1278.

Dr. Carlisle's primary practice is Wasatch Vascular Care - Salt Lake City in Salt Lake City, Utah. Dr. Carlisle is also affiliated with St. Mark's Hospital. The medical group on file is Azura Vascular Care. Dmand AI also links Dr. Carlisle to 4 more hospitals, 5 group practices and clinics, 4 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carlisle practices, 12 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Carlisle's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Carlisle is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Carlisle's licenses on file in 5 states: Utah, California, Ohio, Michigan and Pennsylvania.

CMS data shows 2,142 Medicare services from Dr. Carlisle across 18 procedure codes in 2024, for 590 Medicare patients. Medicare paid $41,542 for them.

CMS counts 590 Medicare patients who saw Dr. Carlisle in 2024. The largest group is 65 to 74, with 246 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 14% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carlisle's median patient age at 64, with 51% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Carlisle for performance year 2024, reported as part of a group. Dr. Carlisle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Carlisle in 2011. 2011 was the busiest year, with 2. Dr. Carlisle's most frequent co-authors are Robert Edward Glasgow, MD and Jason Joel Schwartz, MD.

Dmand AI links Dr. Carlisle to 8 clinical trials. Conditions studied include Carcinoma, Hepatocellular, Liver Neoplasms and Carcinoma, Neuroendocrine. Boston Scientific Corporation sponsors the most, 3.

CMS Open Payments shows 173 general payments to Dr. Carlisle from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Merit Medical Systems Inc paid the most, $23,449.

Dr. Carlisle graduated from University Of Michigan Medical School in 1991. Dr. Carlisle is a member of SIR.

Dr. Carlisle is in network with 5 carriers, including Cigna, Elevance and United Healthcare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.